Proteins Associated with Risk of Kidney Function Decline in the General Population.

TitleProteins Associated with Risk of Kidney Function Decline in the General Population.
Publication TypeJournal Article
Year of Publication2021
AuthorsGrams, ME, Surapaneni, A, Chen, J, Zhou, L, Yu, Z, Dutta, D, Welling, PA, Chatterjee, N, Zhang, J, Arking, DE, Chen, TK, Rebholz, CM, Yu, B, Schlosser, P, Rhee, EP, Ballantyne, CM, Boerwinkle, E, Lutsey, PL, Mosley, T, Feldman, HI, Dubin, RF, Ganz, P, Lee, H, Zheng, Z, Coresh, J
JournalJ Am Soc Nephrol
Volume32
Issue9
Pagination2291-2302
Date Published2021 Sep
ISSN1533-3450
Abstract

BACKGROUND: Proteomic profiling may allow identification of plasma proteins that associate with subsequent changesin kidney function, elucidating biologic processes underlying the development and progression of CKD.

METHODS: We quantified the association between 4877 plasma proteins and a composite outcome of ESKD or decline in eGFR by ≥50% among 9406 participants in the Atherosclerosis Risk in Communities (ARIC) Study (visit 3; mean age, 60 years) who were followed for a median of 14.4 years. We performed separate analyses for these proteins in a subset of 4378 participants (visit 5), who were followed at a later time point, for a median of 4.4 years. For validation, we evaluated proteins with significant associations (false discovery rate

RESULTS: In models adjusted for multiple covariates, including baseline eGFR and albuminuria, we identified 13 distinct proteins that were significantly associated with the composite end point in both time periods, including TNF receptor superfamily members 1A and 1B, trefoil factor 3, and -trace protein. Of these proteins, 12 were also significantly associated in CRIC, and nine were significantly associated in AASK. Higher levels of each protein associated with higher risk of 50% eGFR decline or ESKD. We found genetic evidence for a causal role for one protein, lectin mannose-binding 2 protein (LMAN2).

CONCLUSIONS: Large-scale proteomic analysis identified both known and novel proteomic risk factors for eGFR decline.

DOI10.1681/ASN.2020111607
Alternate JournalJ Am Soc Nephrol
PubMed ID34465608